While CDKN2A (p16INK4a) is classically recognised as a tumour suppressor that inhibits cyclin‐dependent kinases and induces cell cycle arrest [31], emerging evidence suggests context‐dependent oncogenic functions in certain cancer types [32]. This evidence concerns the gene CDKN2A and neoplasm.